Tvardi Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2012 | 10.8% | 10.8% | — |
| FY2013 | 7.3% | 7.3% | -21.9% |
| FY2014 | -34.3% | -34.3% | -31.7% |
| FY2015 | -23.5% | -23.5% | -22.3% |
| FY2016 | -112.9% | -112.9% | -89.7% |
| FY2017 | -67.0% | -67.0% | -59.9% |
| FY2018 | -55.4% | -55.4% | -38.8% |
| FY2019 | -57.0% | -57.0% | -45.7% |
| FY2020 | 3.4% | 3.4% | 3.1% |
| FY2021 | -38.9% | -38.9% | -35.8% |
| FY2022 | -53.8% | -53.8% | -46.9% |
| FY2023 | 191.0% | 191.0% | -94.2% |
| FY2024 | 32.3% | 32.3% | -83.5% |
| FY2025 | -87.0% | -87.0% | -56.8% |